Literature DB >> 8179629

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro.

F Bracht1, K Schrör.   

Abstract

This study was designed to isolate and identify aptamer sequences, acting as thrombin antagonists, from defibrotide, a single-stranded DNA fraction. Two different aptamers were identified: 5'-GGTTGGATTGGTTGG-3' and 5'-GGTTGGATCGGTTGG-3'. A third aptamer: 5'-GGATGGATCGGTTGG-3' was found in the PCR product from the double-stranded defibrotide precursor. All aptamers were potent inhibitors of thrombin-induced platelet aggregation, thromboxane biosynthesis, increase in cytosolic Ca++ and fibrin clot formation, effective concentrations being in the nanomolar range. There was no effect on U 46,619 (thromboxane mimetic) or collagen-induced responses. Similar effects were obtained with unfractionated defibrotide while the "nonsense" oligonucleotide 5'-GGTGGTGGTTGTGGT-3' was inactive. The data suggest that antithrombin effects of defibrotide are caused by aptamers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179629     DOI: 10.1006/bbrc.1994.1539

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  The use of defibrotide in blood and marrow transplantation.

Authors:  Paul G Richardson; Enric Carreras; Massimo Iacobelli; Bijan Nejadnik
Journal:  Blood Adv       Date:  2018-06-26

3.  Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.

Authors:  Ivo M B Francischetti; Carlo J Oliveira; Graciela R Ostera; Stephanie B Yager; Françoise Debierre-Grockiego; Vanessa Carregaro; Giovanna Jaramillo-Gutierrez; Jen C C Hume; Lubin Jiang; Samuel E Moretz; Christina K Lin; José M C Ribeiro; Carole A Long; Brandi K Vickers; Ralph T Schwarz; Karl B Seydel; Massimo Iacobelli; Hans C Ackerman; Prakash Srinivasan; Regis B Gomes; Xunde Wang; Robson Q Monteiro; Michail Kotsyfakis; Anderson Sá-Nunes; Michael Waisberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

4.  Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury.

Authors:  T Murohara; M Buerke; A M Lefer
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 5.  Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2014-12       Impact factor: 2.859

6.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Authors:  Paul G Richardson; Robert J Soiffer; Joseph H Antin; Hajime Uno; Zhezhen Jin; Joanne Kurtzberg; Paul L Martin; Gideon Steinbach; Karen F Murray; Georgia B Vogelsang; Allen R Chen; Amrita Krishnan; Nancy A Kernan; David E Avigan; Thomas R Spitzer; Howard M Shulman; Donald N Di Salvo; Carolyn Revta; Diane Warren; Parisa Momtaz; Gary Bradwin; L J Wei; Massimo Iacobelli; George B McDonald; Eva C Guinan
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

7.  An insight into the sialome of Glossina morsitans morsitans.

Authors:  Juliana Alves-Silva; José M C Ribeiro; Jan Van Den Abbeele; Geoffrey Attardo; Zhengrong Hao; Lee R Haines; Marcelo B Soares; Matthew Berriman; Serap Aksoy; Michael J Lehane
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

8.  Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.

Authors:  Constantine S Mitsiades; Cecile Rouleau; Cinara Echart; Krishna Menon; Beverly Teicher; Maria Distaso; Antonio Palumbo; Mario Boccadoro; Kenneth C Anderson; Massimo Iacobelli; Paul G Richardson
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

Review 9.  Antiplatelet drugs. A comparative review.

Authors:  K Schrör
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

10.  Selecting Molecular Recognition. What Can Existing Aptamers Tell Us about Their Inherent Recognition Capabilities and Modes of Interaction?

Authors:  Qian Zhang; Ralf Landgraf
Journal:  Pharmaceuticals (Basel)       Date:  2012-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.